Moll UM - Search Results

1

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

Marabese M, Marchini S, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Signorelli M, Moll UM, Codegoni AM, Broggini M. Marabese M, et al. Among authors: moll um. Eur J Cancer. 2008 Jan;44(1):131-41. doi: 10.1016/j.ejca.2007.10.011. Epub 2007 Nov 26. Eur J Cancer. 2008. PMID: 18039564 Free PMC article.

2

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, Zeillinger R, Marth C, Moll UM. Concin N, et al. Among authors: moll um. Cancer Res. 2004 Apr 1;64(7):2449-60. doi: 10.1158/0008-5472.can-03-1060. Cancer Res. 2004. PMID: 15059898

3

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.

Concin N, Hofstetter G, Berger A, Gehmacher A, Reimer D, Watrowski R, Tong D, Schuster E, Hefler L, Heim K, Mueller-Holzner E, Marth C, Moll UM, Zeimet AG, Zeillinger R. Concin N, et al. Among authors: moll um. Clin Cancer Res. 2005 Dec 1;11(23):8372-83. doi: 10.1158/1078-0432.CCR-05-0899. Clin Cancer Res. 2005. PMID: 16322298

4

Overexpression of the wild type p73 gene in breast cancer tissues and cell lines.

Zaika AI, Kovalev S, Marchenko ND, Moll UM. Zaika AI, et al. Among authors: moll um. Cancer Res. 1999 Jul 1;59(13):3257-63. Cancer Res. 1999. PMID: 10397274

5

Patterns of p73 N-terminal isoform expression and p53 status have prognostic value in gynecological cancers.

Becker K, Pancoska P, Concin N, Vanden Heuvel K, Slade N, Fischer M, Chalas E, Moll UM. Becker K, et al. Among authors: moll um. Int J Oncol. 2006 Oct;29(4):889-902. Int J Oncol. 2006. PMID: 16964385

6

Akt-mediated cisplatin resistance in ovarian cancer: modulation of p53 action on caspase-dependent mitochondrial death pathway.

Yang X, Fraser M, Moll UM, Basak A, Tsang BK. Yang X, et al. Among authors: moll um. Cancer Res. 2006 Mar 15;66(6):3126-36. doi: 10.1158/0008-5472.CAN-05-0425. Cancer Res. 2006. PMID: 16540663

7

p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Braun CJ, Zhang X, Savelyeva I, Wolff S, Moll UM, Schepeler T, Ørntoft TF, Andersen CL, Dobbelstein M. Braun CJ, et al. Among authors: moll um. Cancer Res. 2008 Dec 15;68(24):10094-104. doi: 10.1158/0008-5472.CAN-08-1569. Cancer Res. 2008. PMID: 19074875 Free PMC article.

8

p63 and p73: roles in development and tumor formation.

Moll UM, Slade N. Moll UM, et al. Mol Cancer Res. 2004 Jul;2(7):371-86. Mol Cancer Res. 2004. PMID: 15280445 Review.

9

While p73 is essential, p63 is completely dispensable for the development of the central nervous system.

Holembowski L, Schulz R, Talos F, Scheel A, Wolff S, Dobbelstein M, Moll U. Holembowski L, et al. Cell Cycle. 2011 Feb 15;10(4):680-9. doi: 10.4161/cc.10.4.14859. Epub 2011 Feb 15. Cell Cycle. 2011. PMID: 21293190 Free PMC article.

10

Role of p53 family members p73 and p63 in human hematological malignancies.

Alexandrova EM, Moll UM. Alexandrova EM, et al. Among authors: moll um. Leuk Lymphoma. 2012 Nov;53(11):2116-29. doi: 10.3109/10428194.2012.684348. Epub 2012 May 21. Leuk Lymphoma. 2012. PMID: 22497596 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

175 results

Search Page